HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetic Microbeads Regulation Could Set Tone For Microfiber Response

This article was originally published in The Rose Sheet

Executive Summary

Research suggests that plastic microbeads used in personal-care products contribute to around 13% of marine plastic pollution, but roughly 85% is attributed to plastic microfibers from clothing. Biomaterial firm TerraVerdae BioWorks is watching personal-care microbeads legislation due to its stake in next-generation, bioplastic microbeads, but its broader concern is how the regulatory movement could influence the next to come.

You may also be interested in...



Mango Materials Champions Opportunity For 'Naturally Occurring Biopolymer' Use

The US Microbead-Free Waters Act bans use of plastic microbeads in rinse-off exfoliating or cleansing cosmetics, but Mango Materials’ “naturally occurring biopolymer” isn’t plastic by most standards. Regardless, it can be used in other cosmetic product categories and as an alternative to conventional plastic packaging, so long as future regulation in the US and abroad doesn’t needlessly prohibit the material’s use, the company says.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel